Journal: Pharmaceutics (ISSN 1999-4923, IF 3.746) Special Issue Name: Computational Drug Repurposing Special Issue Link: https://www.mdpi.com/si/pharmaceutics/computational_drug_repurposing Deadline for manuscript submissions: 31 May 2019 Instructions for authors: https://www.mdpi.com/journal/pharmaceutics/instructions Please submit via: http://susy.mdpi.com Special Issue Editors: Prof. Dr. Ram Samudrala Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA Dr. Zackary Falls Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA Message from the Guest Editors: Dear Colleagues, Computational drug repurposing, i.e., finding new treatments for diseases using FDA approved drugs via computational methods, is one alternative method for increasing the efficacy of pharmaceutical research. Using modern computational tools to narrow the search for efficacious drugs from a pool of drugs greatly decreases cost. Furthermore, since all of the drugs being considered are FDA-approved, their toxicity and side effects profile are known, and the time from bench-to-bedside for a new indication is reduced as they have already been subjected to clinical trials. Though many different approaches are being taken for drug repurposing, there has been no effort to assemble a comprehensive collection of knowledge of this field, specifically focused on computational methods, to have as a reference for novices and experts alike. In this Special Issue of Pharmaceutics, an understanding of how state-of-the-art computational drug repurposing methods make the drug-discovery process more efficient, as well as the juxtaposition of drug repurposing and drugdesign methods, will be comprehensively explored. Prof. Dr. Ram Samudrala Dr. Zackary Falls Guest Editors
|